Literature DB >> 23373549

Toxic epidermal necrolysis and antifolate drugs in cancer chemotherapy.

Claudine Pierard-Franchimont1, Marianne Lesuisse, Philippe Humbert, Philippe Delvenne, Gerald E Pierard.   

Abstract

Folates are one-carbon donors essential for synthesizing purines, pyrimidines, serine, and methionine. They correspond to anionic hydrophilic molecules essential for DNA synthesis in mammalian cells. The latter cells lack the capacity to synthesize folates. In some patients, high dosages of antifolate drugs (eg: methotrexate, pemetrexed) used in cancer chemotherapy alter the keratinocytes, endothelial cells and Factor XIIIa+ dermal dendrocytes in a range of various severities. Such conditions clinically designed under the heading antifolate cytotoxic skin reaction (ACSR) occasionally resemble the toxic epidermal necrolysis (TEN) / Stevens-Johnson syndrome (SJS) spectrum. Whether or not the TEN/SJS presentation of ACSR is a regular condition similar to that induced by other drugs or a variant condition supported by a unique pathomechanism is unsettled.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23373549     DOI: 10.2174/157488612805076543

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  4 in total

Review 1.  Mechanisms, Management and Prevention of Pemetrexed-Related Toxicity.

Authors:  Nikki de Rouw; Berber Piet; Hieronymus J Derijks; Michel M van den Heuvel; Rob Ter Heine
Journal:  Drug Saf       Date:  2021-11-06       Impact factor: 5.606

2.  Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplification.

Authors:  Thanh H Nguyen; Prasantha L Vemu; Gregory E Hoy; Salah Boudjadi; Bishwanath Chatterjee; Jack F Shern; Javed Khan; Wenyue Sun; Frederic G Barr
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

Review 3.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

4.  Pembrolizumab-induced toxic epidermal necrolysis: case report.

Authors:  Kar Ven Cavan Chow; Connor O'Leary; Fiona Paxton-Hall; Duncan Lambie; Kenneth O'Byrne
Journal:  Oxf Med Case Reports       Date:  2022-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.